跳至主要内容
临床试验/IRCT2014101119489N1
IRCT2014101119489N1已完成3 期

Effect of rose oil (Rosa damascena) softgel on cardinal manifestations of patients with gastro-esophageal reflux disease in comparison with omeprazole capsule, a double blind randomized controlled trial

Tehran University of Medical Sciences, Vice chancellor for research and technology0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
16 years 至 80 years(—)
性别
All

入选标准

  • Patients between 16 to 80 years old; Patients have at least 12 weeks history of GERD; No history of barrett's esophagus; No history of surgery on esophagus or stomach; No history of any cancer in esophagus, stomach or abdomen; No coagulation problem unable to withdrawal of drugs; No use of glucocorticoids and NSAIDs more than 3 days a week during last 28 days; No sucralfate use during 3 days before study; No aspirin use more than 150 mg daily; No active peptic ulcer or its complications; No antibiotic use for H. pylori eradication during last 28 days; No Cigarette smoking or alcohol drinking; Absence of any GERD complication.
  • Exclusion criteria:
  • Appearance of drug adverse effects; Loss of patient compliance

排除标准

  • 未提供

研究者

发起方
Tehran University of Medical Sciences, Vice chancellor for research and technology

相似试验